BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 19498036)

  • 1. Expansion of the Parkinson disease-associated SNCA-Rep1 allele upregulates human alpha-synuclein in transgenic mouse brain.
    Cronin KD; Ge D; Manninger P; Linnertz C; Rossoshek A; Orrison BM; Bernard DJ; El-Agnaf OM; Schlossmacher MG; Nussbaum RL; Chiba-Falek O
    Hum Mol Genet; 2009 Sep; 18(17):3274-85. PubMed ID: 19498036
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of alpha-synuclein expression by poly (ADP ribose) polymerase-1 (PARP-1) binding to the NACP-Rep1 polymorphic site upstream of the SNCA gene.
    Chiba-Falek O; Kowalak JA; Smulson ME; Nussbaum RL
    Am J Hum Genet; 2005 Mar; 76(3):478-92. PubMed ID: 15672325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypomethylation of SNCA in blood of patients with sporadic Parkinson's disease.
    Ai SX; Xu Q; Hu YC; Song CY; Guo JF; Shen L; Wang CR; Yu RL; Yan XX; Tang BS
    J Neurol Sci; 2014 Feb; 337(1-2):123-8. PubMed ID: 24326201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of allelic variation at the NACP-Rep1 repeat upstream of the alpha-synuclein gene (SNCA) on transcription in a cell culture luciferase reporter system.
    Chiba-Falek O; Nussbaum RL
    Hum Mol Genet; 2001 Dec; 10(26):3101-9. PubMed ID: 11751692
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Yong AC; Tan YJ; Zhao Y; Lu Z; Ng EY; Ng SY; Chia NS; Choi X; Heng D; Neo S; Xu Z; Tay KY; Au WL; Tan EK; Tan LC; Ng AS
    Aging (Albany NY); 2020 Oct; 12(20):20880-20887. PubMed ID: 33082300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic regulation of alpha-synuclein mRNA expression in various human brain tissues.
    Linnertz C; Saucier L; Ge D; Cronin KD; Burke JR; Browndyke JN; Hulette CM; Welsh-Bohmer KA; Chiba-Falek O
    PLoS One; 2009 Oct; 4(10):e7480. PubMed ID: 19834617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. α-Synuclein BAC transgenic mice exhibit RBD-like behaviour and hyposmia: a prodromal Parkinson's disease model.
    Taguchi T; Ikuno M; Hondo M; Parajuli LK; Taguchi K; Ueda J; Sawamura M; Okuda S; Nakanishi E; Hara J; Uemura N; Hatanaka Y; Ayaki T; Matsuzawa S; Tanaka M; El-Agnaf OMA; Koike M; Yanagisawa M; Uemura MT; Yamakado H; Takahashi R
    Brain; 2020 Jan; 143(1):249-265. PubMed ID: 31816026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Collaborative analysis of alpha-synuclein gene promoter variability and Parkinson disease.
    Maraganore DM; de Andrade M; Elbaz A; Farrer MJ; Ioannidis JP; Krüger R; Rocca WA; Schneider NK; Lesnick TG; Lincoln SJ; Hulihan MM; Aasly JO; Ashizawa T; Chartier-Harlin MC; Checkoway H; Ferrarese C; Hadjigeorgiou G; Hattori N; Kawakami H; Lambert JC; Lynch T; Mellick GD; Papapetropoulos S; Parsian A; Quattrone A; Riess O; Tan EK; Van Broeckhoven C;
    JAMA; 2006 Aug; 296(6):661-70. PubMed ID: 16896109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does α-synuclein have a dual and opposing effect in preclinical vs. clinical Parkinson's disease?
    Markopoulou K; Biernacka JM; Armasu SM; Anderson KJ; Ahlskog JE; Chase BA; Chung SJ; Cunningham JM; Farrer M; Frigerio R; Maraganore DM
    Parkinsonism Relat Disord; 2014 Jun; 20(6):584-9; discussion 584. PubMed ID: 24656894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SNCA variant associated with Parkinson disease and plasma alpha-synuclein level.
    Mata IF; Shi M; Agarwal P; Chung KA; Edwards KL; Factor SA; Galasko DR; Ginghina C; Griffith A; Higgins DS; Kay DM; Kim H; Leverenz JB; Quinn JF; Roberts JW; Samii A; Snapinn KW; Tsuang DW; Yearout D; Zhang J; Payami H; Zabetian CP
    Arch Neurol; 2010 Nov; 67(11):1350-6. PubMed ID: 21060011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. alpha-Synuclein and Parkinson disease susceptibility.
    Winkler S; Hagenah J; Lincoln S; Heckman M; Haugarvoll K; Lohmann-Hedrich K; Kostic V; Farrer M; Klein C
    Neurology; 2007 Oct; 69(18):1745-50. PubMed ID: 17872362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcript expression levels of full-length alpha-synuclein and its three alternatively spliced variants in Parkinson's disease brain regions and in a transgenic mouse model of alpha-synuclein overexpression.
    McLean JR; Hallett PJ; Cooper O; Stanley M; Isacson O
    Mol Cell Neurosci; 2012 Feb; 49(2):230-9. PubMed ID: 22155155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alpha-synuclein, alcohol use disorders, and Parkinson disease: a case-control study.
    Brighina L; Schneider NK; Lesnick TG; de Andrade M; Cunningham JM; Mrazek D; Rocca WA; Maraganore DM
    Parkinsonism Relat Disord; 2009 Jul; 15(6):430-4. PubMed ID: 19196539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of SNCA variants with α-synuclein of gastric and colonic mucosa in Parkinson's disease.
    Chung SJ; König IR; Lohmann K; Hinrichs F; Kim J; Ryu HS; Lee HJ; Kim K; Lee JH; Jung KW; Kim MJ; Kim MJ; Kim YJ; Yun SC; Hong SM; Myung SJ; Klein C
    Parkinsonism Relat Disord; 2019 Apr; 61():151-155. PubMed ID: 30424941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SNCA Rep1 promoter variability influences cognition in Parkinson's disease.
    Ng ASL; Tan YJ; Zhao Y; Saffari SE; Lu Z; Ng EYL; Ng SYE; Chia NSY; Setiawan F; Xu Z; Tay KY; Au WL; Tan LCS; Tan EK
    Mov Disord; 2019 Aug; 34(8):1232-1236. PubMed ID: 31234238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The PD-associated alpha-synuclein promoter Rep1 allele 2 shows diminished frequency in restless legs syndrome.
    Lahut S; Vadasz D; Depboylu C; Ries V; Krenzer M; Stiasny-Kolster K; Basak AN; Oertel WH; Auburger G
    Neurogenetics; 2014 Aug; 15(3):189-92. PubMed ID: 24863655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Longitudinal Study of SNCA Rep1 Polymorphism on Executive Function in Early Parkinson's Disease.
    Tan YJ; Saffari SE; Zhao Y; Ng EYL; Yong ACW; Ng SYE; Chia NSY; Choi X; Heng D; Neo S; Xu Z; Tay KY; Au WL; Tan EK; Tan LCS; Ng ASL
    J Parkinsons Dis; 2022; 12(3):865-870. PubMed ID: 35068417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SNCA REP1 and Parkinson's disease.
    Shu L; Zhang Y; Sun Q; Pan H; Guo J; Tang B
    Neurosci Lett; 2018 Aug; 682():79-84. PubMed ID: 29859327
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Levels of alpha-synuclein mRNA in sporadic Parkinson disease patients.
    Chiba-Falek O; Lopez GJ; Nussbaum RL
    Mov Disord; 2006 Oct; 21(10):1703-8. PubMed ID: 16795004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Familial genes in sporadic disease: common variants of alpha-synuclein gene associate with Parkinson's disease.
    Ross OA; Gosal D; Stone JT; Lincoln SJ; Heckman MG; Irvine GB; Johnston JA; Gibson JM; Farrer MJ; Lynch T
    Mech Ageing Dev; 2007; 128(5-6):378-82. PubMed ID: 17531291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.